Compare GILT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | PACB |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 599.3M | 696.3M |
| IPO Year | 1997 | 2010 |
| Metric | GILT | PACB |
|---|---|---|
| Price | $4.97 | $1.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $12.15 | $2.74 |
| AVG Volume (30 Days) | 1.2M | ★ 12.4M |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $3.05 | N/A |
| Revenue Next Year | $12.61 | $14.03 |
| P/E Ratio | $42.82 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $5.09 | $1.07 |
| 52 Week High | $20.99 | $3.44 |
| Indicator | GILT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 22.00 | 42.61 |
| Support Level | N/A | $1.27 |
| Resistance Level | $10.39 | $2.00 |
| Average True Range (ATR) | 0.34 | 0.26 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 0.35 | 15.14 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.